Literature DB >> 19249440

Commentary PCSK9 variants: A new database.

Sarah E A Leigh, Trond P Leren, Steve E Humphries.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19249440     DOI： 10.1016/j.atherosclerosis.2009.02.006

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  11 in total

Review 1.  The influence of PCSK9 polymorphisms on serum low-density lipoprotein cholesterol and risk of atherosclerosis.

Authors:  Jean Davignon; Geneviève Dubuc; Nabil G Seidah
Journal:  Curr Atheroscler Rep       Date:  2010-09       Impact factor: 5.113

2.  Stepwise processing analyses of the single-turnover PCSK9 protease reveal its substrate sequence specificity and link clinical genotype to lipid phenotype.

Authors:  John S Chorba; Adri M Galvan; Kevan M Shokat
Journal:  J Biol Chem       Date:  2017-12-19       Impact factor: 5.157

Review 3.  The biology and therapeutic targeting of the proprotein convertases.

Authors:  Nabil G Seidah; Annik Prat
Journal:  Nat Rev Drug Discov       Date:  2012-05       Impact factor: 84.694

Review 4.  Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk.

Authors:  Sebastiano Calandra; Patrizia Tarugi; Helen E Speedy; Andrew F Dean; Stefano Bertolini; Carol C Shoulders
Journal:  J Lipid Res       Date:  2011-08-23       Impact factor: 5.922

5.  Molecular Characterization of Familial Hypercholesterolemia in a North American Cohort.

Authors:  Abhimanyu Garg; Sergio Fazio; P Barton Duell; Alexis Baass; Chandrasekhar Udata; Tenshang Joh; Tom Riel; Marina Sirota; Danielle Dettling; Hong Liang; Pamela D Garzone; Barry Gumbiner; Hong Wan
Journal:  J Endocr Soc       Date:  2019-11-29

Review 6.  The biology of PCSK9 from the endoplasmic reticulum to lysosomes: new and emerging therapeutics to control low-density lipoprotein cholesterol.

Authors:  Steve Poirier; Gaétan Mayer
Journal:  Drug Des Devel Ther       Date:  2013-10-04       Impact factor: 4.162

Review 7.  The genetics and screening of familial hypercholesterolaemia.

Authors:  Raymond Henderson; Maurice O'Kane; Victoria McGilligan; Steven Watterson
Journal:  J Biomed Sci       Date:  2016-04-16       Impact factor: 8.410

8.  Blood lipid-related low-frequency variants in LDLR and PCSK9 are associated with onset age and risk of myocardial infarction in Japanese.

Authors:  Tomoyuki Tajima; Hiroyuki Morita; Kaoru Ito; Tsutomu Yamazaki; Michiaki Kubo; Issei Komuro; Yukihide Momozawa
Journal:  Sci Rep       Date:  2018-05-25       Impact factor: 4.379

Review 9.  PCSK9 Biology and Its Role in Atherothrombosis.

Authors:  Cristina Barale; Elena Melchionda; Alessandro Morotti; Isabella Russo
Journal:  Int J Mol Sci       Date:  2021-05-30       Impact factor: 5.923

Review 10.  Proprotein convertase subtilisin/kexin type 9: from the discovery to the development of new therapies for cardiovascular diseases.

Authors:  Nicola Ferri
Journal:  Scientifica (Cairo)       Date:  2012-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.